Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions.
about
The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the LiteratureSpinal cord tumours: advances in genetics and their implications for treatmentAn update on vaccine therapy and other immunotherapeutic approaches for glioblastomaMolecular heterogeneity in glioblastoma: potential clinical implicationsNitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.The ketogenic diet for the treatment of malignant glioma.Surgical delivery of drug releasing poly(lactic-co-glycolic acid)/poly(ethylene glycol) paste with in vivo effects against glioblastoma.Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry.Biological and clinical implications of cancer stem cells in primary brain tumors.Interleukins in glioblastoma pathophysiology: implications for therapy.Therapeutic application of monoclonal antibodies in cancer: advances and challenges.Glioblastoma multiforme: State of the art and future therapeutics.Molecular and genetic pathways in gliomas: the future of personalized therapeutics.PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186.Vaccinia virus expressing bone morphogenetic protein-4 in novel glioblastoma orthotopic models facilitates enhanced tumor regression and long-term survival.Molecular markers in glioma.p38γ overexpression in gliomas and its role in proliferation and apoptosis.Targeted antiepidermal growth factor receptor (cetuximab) immunoliposomes enhance cellular uptake in vitro and exhibit increased accumulation in an intracranial model of glioblastoma multiforme.Chlorotoxin-conjugated onconase as a potential anti-glioma drug.ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways.Molecular Markers of Therapy-Resistant Glioblastoma and Potential Strategy to Combat Resistance.
P2860
Q26800604-1A6E2DC1-E335-48AC-89E1-6EBE9EC99EFBQ26851596-8058FBC2-1F5C-4977-B0B7-8F739452225FQ27024830-4586F951-086A-4AA7-9EA6-F2FB0CAC656FQ28088605-0FD3ACE5-76D9-4CF8-9BDC-0EBBFAB52629Q30431810-F616250E-B271-4195-8ACF-693F94A8433AQ34757474-850AC6EC-87CF-4C13-AB61-1DB63918593AQ35758314-EA078520-2AA4-46E3-8945-44F8FDDF8425Q36179288-019C8616-A531-45EE-9778-518730551FFAQ36562573-08EE1627-54C4-404B-91F3-73A52E4C1B51Q38051761-1881A8E1-EBDE-415C-B6C9-C6C2E09AA725Q38057179-FF239ABA-E19C-44FB-8F0A-1B8F287CD59DQ38225874-0CBA6AB3-6D55-45C3-8035-49BF5A989A87Q38233171-E9ADDBB4-D7FF-4DEE-9F1D-30065BFE7C2AQ38738395-A3C01D7E-8D44-4704-8313-220A5D7B2E55Q39135169-E4ABA781-0214-48A8-8580-4001B6692238Q39148751-BBFFE239-A9AF-4BC4-9AAD-D4E2C9338E50Q41513737-C53ED942-05BC-418A-ABB8-7273B352E77CQ42120982-FCED2B86-5DD6-4253-80A1-63764869D638Q43128710-092F8070-F47A-4EB9-BBFD-D62EE5C9F35EQ48178463-4FA9F05B-1BEF-4866-AC7C-6D5F9EE93C0EQ55663256-6DF90E98-BFAD-497E-A051-D8A994EF2B66
P2860
Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular targeted therapy in ...... llenges and future directions.
@en
type
label
Molecular targeted therapy in ...... llenges and future directions.
@en
prefLabel
Molecular targeted therapy in ...... llenges and future directions.
@en
P2093
P2860
P1476
Molecular targeted therapy in ...... llenges and future directions.
@en
P2093
Manmeet S Ahluwalia
Michael A Vogelbaum
Mital Patel
Rakesh Jalali
P2860
P304
P356
10.1517/13543784.2012.703177
P407
P577
2012-06-25T00:00:00Z